Synergistic antifungal effect of glabridin and fluconazole

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Liu, Wei ^a   Li, Li Ping ^a   Zhang, Jun Dong ^a   Li, Qun ^a   Shen, Hui ^a   Chen, Si Min ^a   He, Li Juan ^a   Yan, Lan ^b   Xu, Guo Tong ^a   An, Mao Mao ^a   Jiang, Yuan Ying ^a,b  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE; GLABRIDIN; ANTIFUNGAL AGENT; ISOFLAVONE DERIVATIVE; PHENOL DERIVATIVE;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CELL GROWTH; CELL MEMBRANE PERMEABILITY; CELL SIZE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; DISK DIFFUSION; DRUG POTENTIATION; FRACTIONAL INHIBITORY CONCENTRATION INDEX; FUNGAL CELL; FUNGAL MEMBRANE; FUNGAL STRAIN; MEMBRANE DAMAGE; MICROBIOLOGY TEST; MINIMAL FUNGICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; TIME KILLING TEST; ANTIFUNGAL RESISTANCE; CANDIDA; CELL WALL; CLASSIFICATION; DOSE RESPONSE; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; MICROBIAL SENSITIVITY TEST;

ANTIFUNGAL AGENTS; CANDIDA; CELL WALL; CRYPTOCOCCUS NEOFORMANS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, FUNGAL; DRUG SYNERGISM; FLUCONAZOLE; ISOFLAVONES; MICROBIAL SENSITIVITY TESTS; PHENOLS;

EID: 84904810884     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0103442     Document Type: Article

References (34)

1. Pukkila-Worley R, Mylonakis E (2008) Epidemiology and management of cryptococcal meningitis: developments and challenges. Expert Opin Pharmacother 9: 551-560. (Pubitemid 351425383)
2. Warnock DW (2007) Trends in the epidemiology of invasive fungal infections. Nihon Ishinkin Gakkai Zasshi 48: 1-12.
3. Morace G, Borghi E (2010) Fungal infections in ICU patients: epidemiology and the role of diagnostics. Minerva Anestesiol 76: 950-956.
4. Yapar N, Pullukcu H, Avkan-Oguz V, Sayin-Kutlu S, Ertugrul B, et al. (2011) Evaluation of species distribution and risk factors of candidemia: a multicenter case-control study. Med Mycol 49: 26-31.
5. Zirkel J, Klinker H, Kuhn A, Abele-Horn M, Tappe D, et al. (2012) Epidemiology of Candida blood stream infections in patients with hematological malignancies or solid tumors. Med Mycol 50: 50-55.
6. Horn DL, Neofytos D, Anaissie EJ, Fishman JA, Steinbach WJ, et al. (2009) Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis 48: 1695-1703.
7. Sun L, Sun S, Cheng A, Wu X, Zhang Y, et al. (2009) In vitro activities of retigeric acid B alone and in combination with azole antifungal agents against Candida albicans. Antimicrob Agents Chemother 53: 1586-1591.
8. Chang W, Li Y, Zhang L, Cheng A, Liu Y, et al. (2012) Retigeric acid B enhances the efficacy of azoles combating the virulence and biofilm formation of Candida albicans. Biol Pharm Bull 35: 1794-1801.
9. Guo XL, Leng P, Yang Y, Yu LG, Lou HX (2008) Plagiochin E, a botanic-derived phenolic compound, reverses fungal resistance to fluconazole relating to the efflux pump. J Appl Microbiol 104: 831-838. (Pubitemid 351257751)
10. Quan H, Cao YY, Xu Z, Zhao JX, Gao PH, et al. (2006) Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole. Antimicrob Agents Chemother 50: 1096-1099. (Pubitemid 43327820)
11. Huang S, Cao YY, Dai BD, Sun XR, Zhu ZY, et al. (2008) In vitro synergism of fluconazole and baicalein against clinical isolates of Candida albicans resistant to fluconazole. Biol Pharm Bull 31: 2234-2236.
12. An M, Shen H, Cao Y, Zhang J, Cai Y, et al. (2009) Allicin enhances the oxidative damage effect of amphotericin B against Candida albicans. Int J Antimicrob Agents 33: 258-263.
13. Sharma M, Manoharlal R, Negi AS, Prasad R (2010) Synergistic anticandidal activity of pure polyphenol curcumin I in combination with azoles and polyenes generates reactive oxygen species leading to apoptosis. FEMS Yeast Res 10: 570-578.
14. Guo N, Ling G, Liang X, Jin J, Fan J, et al. (2011) In vitro synergy of pseudolaric acid B and fluconazole against clinical isolates of Candida albicans. Mycoses 54: e400-406.
15. Ahmad A, Khan A, Khan LA, Manzoor N (2010) In vitro synergy of eugenol and methyleugenol with fluconazole against clinical Candida isolates. J Med Microbiol 59: 1178-1184.
16. Belinky PA, Aviram M, Fuhrman B, Rosenblat M, Vaya J (1998) The antioxidative effects of the isoflavan glabridin on endogenous constituents of LDL during its oxidation. Atherosclerosis 137: 49-61. (Pubitemid 28175376)
17. Carmeli E, Harpaz Y, Kogan NN, Fogelman Y (2008) The effect of an endogenous antioxidant glabridin on oxidized LDL. J Basic Clin Physiol Pharmacol 19: 49-63.
18. Hasanein P (2011) Glabridin as a major active isoflavan from Glycyrrhiza glabra (licorice) reverses learning and memory deficits in diabetic rats. Acta Physiol Hung 98: 221-230.
19. Shang H, Cao S, Wang J, Zheng H, Putheti R (2010) Glabridin from Chinese herb licorice inhibits fatigue in mice. Afr J Tradit Complement Altern Med 7: 17-23.
20. Tsai YM, Yang CJ, Hsu YL, Wu LY, Tsai YC, et al. (2011) Glabridin inhibits migration, invasion, and angiogenesis of human non-small cell lung cancer A549 cells by inhibiting the FAK/rho signaling pathway. Integr Cancer Ther 10: 341-349.
21. Kwon HS, Oh SM, Kim JK (2008) Glabridin, a functional compound of liquorice, attenuates colonic inflammation in mice with dextran sulphate sodium-induced colitis. Clin Exp Immunol 151: 165-173.
22. Hsu YL, Wu LY, Hou MF, Tsai EM, Lee JN, et al. (2011) Glabridin, an isoflavan from licorice root, inhibits migration, invasion and angiogenesis of MDA-MB-231 human breast adenocarcinoma cells by inhibiting focal adhesion kinase/Rho signaling pathway. Mol Nutr Food Res 55: 318-327.
23. Yu XQ, Xue CC, Zhou ZW, Li CG, Du YM, et al. (2008) In vitro and in vivo neuroprotective effect and mechanisms of glabridin, a major active isoflavan from Glycyrrhiza glabra (licorice). Life Sci 82: 68-78. (Pubitemid 350251394)
24. Fatima A, Gupta VK, Luqman S, Negi AS, Kumar JK, et al. (2009) Antifungal activity of Glycyrrhiza glabra extracts and its active constituent glabridin. Phytother Res 23: 1190-1193.
25. Messier C, Grenier D (2011) Effect of licorice compounds licochalcone A, glabridin and glycyrrhizic acid on growth and virulence properties of Candida albicans. Mycoses 54: e801-806.
26. Roling EE, Klepser ME, Wasson A, Lewis RE, Ernst EJ, et al. (2002) Antifungal activities of fluconazole, caspofungin (MK0991), and anidulafungin (LY 303366) alone and in combination against Candida spp. and Crytococcus neoformans via time-kill methods. Diagn Microbiol Infect Dis 43: 13-17. (Pubitemid 34607512)
27. Tanida T, Okamoto T, Ueta E, Yamamoto T, Osaki T (2006) Antimicrobial peptides enhance the candidacidal activity of antifungal drugs by promoting the efflux of ATP from Candida cells. Journal of Antimicrobial Chemotherapy 57: 94-103. (Pubitemid 43057064)
28. Di Santo R (2010) Natural products as antifungal agents against clinically relevant pathogens. Nat Prod Rep 27: 1084-1098.
29. Motsei ML, Lindsey KL, van Staden J, Jager AK (2003) Screening of traditionally used South African plants for antifungal activity against Candida albicans. J Ethnopharmacol 86: 235-241. (Pubitemid 36542883)
30. Hojo H, Sato J (2002) Antifungal activity of licorice (Glycyrrhiza Glabra) and potential applications to production of beverages. Foods Food Ingredients J Jpn 203: 27-33.
31. Fu Z, Lu H, Zhu Z, Yan L, Jiang Y, et al. (2011) Combination of baicalein and Amphotericin B accelerates Candida albicans apoptosis. Biol Pharm Bull 34: 214-218.
32. Sun LM, Cheng AX, Wu XZ, Zhang HJ, Lou HX (2010) Synergistic mechanisms of retigeric acid B and azoles against Candida albicans. J Appl Microbiol 108: 341-348.
33. Lee JA, Chee HY (2010) In Vitro Antifungal Activity of Equol against Candida albicans. Mycobiology 38: 328-330.
34. da Silva CR, de Andrade Neto JB, de Sousa Campos R, Figueiredo NS, Serpa Sampaio L, et al. (2014) Synergistic Effect of the Flavonoid Catechin, Quercetin, or Epigallocatechin Gallate with Fluconazole Induces Apoptosis in Candida tropicalis Resistant to Fluconazole. Antimicrobial Agents and Chemotherapy 58: 1468-1478.